Navigation Links
ARUP Laboratories Announces New CMO Appointment
Date:7/6/2009

SALT LAKE CITY, July 6 /PRNewswire/ -- ARUP Laboratories, a national clinical and anatomic pathology reference laboratory and a leader in innovative laboratory research and development, announced today the appointment of Sherrie L. Perkins, MD, PhD, as chief medical officer (CMO) and director of laboratories, effective, July 1, 2009.

Dr. Perkins will be taking over the responsibility from Edward R. Ashwood, MD, who will be transitioning into the role of president and chief executive officer. These transitions will coincide with the announced retirement of ARUP founder and CEO Carl R. Kjeldsberg, MD, on June 30, 2009.

"Dr. Perkins is uniquely qualified to lead ARUP into the future. She has shown superb leadership and a commitment to advancing patient care through laboratory medicine," said Dr. Ashwood.

Dr. Perkins has been with ARUP Laboratories and the University of Utah for 19 years. During this time, she has served in numerous leadership roles including director of hematopathology, interim department chair, and, for the past three years, as a member of the ARUP Laboratories executive management team. She is a tenured professor at the University of Utah School of Medicine, is board certified in anatomic pathology and holds a special qualification in hematology.

Dr. Perkins received her PhD in biochemistry from the University of Miami. She earned her MD and completed her pathology residency at Washington University.

"ARUP has a distinguished history of improving patient care, research, and medical education. I look forward to working with my colleagues to build upon this history," remarked Dr. Perkins.

About ARUP Laboratories

ARUP Laboratories is a national clinical and anatomic pathology reference laboratory and an enterprise of the University of Utah and its Department of Pathology. With more than 2,600 employees, ARUP offers over 2,000 tests and test combinations, ranging from routine screening tests to highly esoteric molecular and genetic assays, for patients throughout the country. ARUP's clients include more than half of the nation's university teaching hospitals and children's hospitals, as well as multihospital groups, major commercial laboratories, group purchasing organizations, military and government facilities, and major clinics. In addition, ARUP is a worldwide leader in innovative laboratory research and development, led by the efforts of the ARUP Institute for Clinical and Experimental Pathology(R). For more information about ARUP Laboratories, including a high-resolution, downloadable photo of Dr. Perkins, please visit http://www.aruplab.com/AboutARUP/PressRoom/PressRelease/2009/2009.07.06.jsp.


'/>"/>
SOURCE ARUP Laboratories
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2010 First Quarter Earnings
2. Caraco Pharmaceutical Laboratories, Ltd. Announces an Indefinite Reduction in its Workforce
3. Caraco Pharmaceutical Laboratories, Ltd. Updates on Financial Position
4. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Action
5. Forest Laboratories Announces Positive Top-line Data from Two Pivotal Phase III Trials of Ceftaroline for the Treatment of Community-acquired Bacterial Pneumonia (CABP) Requiring Hospitalization
6. AirClic Mobile Business Solutions Clic for Bio-Reference Laboratories, Inc.
7. M.A.Z.E. Cord Blood Laboratories Offers Expectant Parents The Chance To Win A $500 Savings Bond
8. Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Fiscal Year 2009, Updates on FDA Inspection
9. IDEXX Laboratories to Present at William Blair 29th Annual Growth Stock Conference
10. Underwriters Laboratories Reminds Parents to Pay Attention to Staycation Safety Hazards
11. Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Roxicodone(R) Tablets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer care, and ... in the eye of the beholder, according to experts who offered insights and commentary ... of Managed Care. For the full issue, click here . , For the ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are ... with endometriosis. These women need a treatment plan to not only alleviate symptoms ... can help for preservation of fertility and ultimately achieving a pregnancy. The specialists ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the largest ... as the Medical Director of its new Mesquite-Samuell Farm facility. , “We are ... Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published ... unfamiliar with. The article goes on to state that individuals are now more comfortable ... less common operations such as calf and cheek reduction. The Los Angeles area medical ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that ... chosen by their peers for this recognition are considered among the top 2 percent ... special honors as members of this year’s Legal Elite Hall of Fame: Miami ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Dialysis Devices Global Market - Forecast to 2022" report ... is the treatment method for the patients with kidney failure, ... and excess fluid from the patient,s blood and thus the ... sodium, potassium and chloride in balance. Increasing ...
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
Breaking Medicine Technology: